• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

    5.870 -0.040 (-0.68%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 29, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

    < Previous 1 2
    ...
    10 11 12 13 14 15 16 17 18
    ...
    20 21 Next >
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
    These companies could stand out thanks to game-changing technology. 
    Via The Motley Fool
    Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock
    Investors in Recursion Pharmaceuticals and RXRX stock have a couple of key catalysts to point to as reasons to buy big right now. 
    Via InvestorPlace
    What's Going On With Recursion Pharmaceuticals Stock?
     
    Via Benzinga
    Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. 
    Via Benzinga
    Topics Stocks
    Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
    Recursion and NVIDIA will host an invite-only event on Wednesday, January 10, where Recursion will provide live demonstrations of LOWE, its new LLM-based software that can perform complex drug... 
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Peering Into Recursion Pharmaceuticals's Recent Short Interest
     
    Via Benzinga
    Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
    U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following... 
    Via Benzinga
    Topics Stocks
    Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
    Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer 
    From Recursion Pharmaceuticals, Inc.
    Via GlobeNewswire
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought in 2024
    The widely followed aggressive growth investor is adding to some of her holdings as she kicks off the new year. 
    Via The Motley Fool
    2 Cathie Wood Stocks That Might Be Smart Buys Right Now
    These two biotech stocks hold enormous potential. 
    Via The Motley Fool
    Looking Into Recursion Pharmaceuticals's Recent Short Interest
     
    Via Benzinga
    Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock
     
    Via Benzinga
    3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
    Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today. 
    Via InvestorPlace
    AI-Focused Drug Discovery Stocks Index Up 26% In December
    With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions. 
    Via Talk Markets
    Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher
    On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before. 
    Via Investor's Business Daily
    Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
    Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets. 
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    3 Genomics Stocks to Unlock the Future of Medicine
    Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use. 
    Via InvestorPlace
    These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
    2024 is going to be a sizzler in the biopharma sector. 
    Via The Motley Fool
    AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
    A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method. 
    Via Talk Markets
    Topics Artificial Intelligence
    AI Meets Biotech: 3 Top Stocks Transforming Medical Science
    The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock
    Wood is moving away from fintech and Internet names like COIN stock. She's now favoring genomics and artificial intelligence companies. 
    Via InvestorPlace
    Topics Artificial Intelligence
    These 9 Micro/Small Cap AI Stocks Continue In Bubble Mode
    9 micro/small cap AI stocks are still in bubble mode advancing 14.8%, on average, last week. In comparison, the Global X Artificial Intelligence & Technology ETF was only up 0.5% and the iShares... 
    Via Talk Markets
    Topics Artificial Intelligence ETFs
    The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week
    If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to... 
    Via Talk Markets
    Topics Artificial Intelligence
    Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
    The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. 
    Via Talk Markets
    Topics Artificial Intelligence
    November Recap: Top 9 Micro/Small Cap AI Stocks Up +53%, On Average
    The top 9 micro- and small-cap AI stocks advanced by 53%, on average, in November. 
    Via Talk Markets
    Topics Artificial Intelligence
    Hewlett Packard Enterprise Posts Upbeat Earnings, Joins Foot Locker, NetApp And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Wednesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) moved higher during Wednesday’s session following... 
    Via Benzinga
    Topics Stocks
    Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.
    Scaling up means having more power to bring to bear on core activities. 
    Via The Motley Fool
    Topics Artificial Intelligence
    2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth
    Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy. 
    Via InvestorPlace
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
    The popular growth investor keeps adding to some of her favorite stocks. 
    Via The Motley Fool
    < Previous 1 2
    ...
    10 11 12 13 14 15 16 17 18
    ...
    20 21 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.